TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 138 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $777,780 | -41.8% | 87,000 | 0.0% | 0.01% | -33.3% |
| Q2 2023 | $1,336,320 | -31.7% | 87,000 | 0.0% | 0.01% | -35.7% |
| Q1 2023 | $1,956,630 | -71.0% | 87,000 | -72.9% | 0.01% | -73.1% |
| Q4 2022 | $6,750,630 | +177782.2% | 321,000 | +108.4% | 0.05% | +62.5% |
| Q3 2022 | $3,795 | -100.0% | 154,000 | -57.1% | 0.03% | -46.7% |
| Q4 2021 | $11,143,000 | +93.1% | 359,000 | +50.8% | 0.06% | +81.8% |
| Q3 2021 | $5,772,000 | +202.0% | 238,000 | +81.7% | 0.03% | +175.0% |
| Q2 2021 | $1,911,000 | +34.9% | 131,000 | +151.9% | 0.01% | +9.1% |
| Q4 2020 | $1,417,000 | – | 52,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 895,821 | $8,008,640 | 3.99% |
| Deep Track Capital, LP | 7,370,000 | $65,887,800 | 2.54% |
| VR Adviser, LLC | 2,623,677 | $23,455,672 | 2.47% |
| Sio Capital Management, LLC | 884,770 | $7,909,844 | 2.45% |
| Kynam Capital Management, LP | 957,502 | $8,560,068 | 1.40% |
| MPM BioImpact LLC | 552,846 | $4,942,443 | 1.32% |
| ARMISTICE CAPITAL, LLC | 7,500,000 | $67,050,000 | 1.03% |
| Parkman Healthcare Partners LLC | 577,494 | $5,162,796 | 0.95% |
| Tri Locum Partners LP | 251,702 | $2,250,216 | 0.72% |
| Cheyne Capital Management (UK) LLP | 26,200 | $234,228 | 0.68% |